Haemolytic disease and the rheasus blood group

Click For Summary
SUMMARY

Haemolytic disease in newborns occurs when an Rh- mother has developed anti-D antibodies that cross the placenta, affecting subsequent Rh+ babies. This condition is particularly relevant after the first pregnancy, as the mother's immune system can produce these antibodies after exposure to Rh+ blood. In contrast, transfusing Rh- blood to an Rh+ recipient is safe because the volume of anti-D antibodies in the transfusion is insufficient to trigger an immune response. Understanding these mechanisms is crucial for managing Rh incompatibility in pregnancies.

PREREQUISITES
  • Knowledge of Rh factor and blood group systems
  • Understanding of maternal-fetal immunology
  • Familiarity with antibody-mediated immune responses
  • Basic concepts of blood transfusion safety
NEXT STEPS
  • Research the mechanisms of Rh incompatibility in pregnancy
  • Study the role of anti-D immunoglobulin in preventing haemolytic disease
  • Explore guidelines for managing Rh-negative pregnancies
  • Learn about blood transfusion protocols for Rh+ and Rh- patients
USEFUL FOR

Medical professionals, obstetricians, hematologists, and anyone involved in prenatal care and blood transfusion practices.

Cheman
Messages
235
Reaction score
1
Haemolytic disease and the rheasus blood group...

Why do you get haemolytic disease in a baby ( not first baby) if the mother is Rh- and her anti D antibodies cross the placenta, yet it is fine to tranfuse Rh- blood to a Rh+ recipient, which will also contain anti D antibodies?

Thanks in advance. :wink:
 
Biology news on Phys.org
I've just noticed there is a slight flaw in my question 4get it. :smile: Sorry.
 

Similar threads

  • · Replies 2 ·
Replies
2
Views
3K
Replies
11
Views
2K
  • · Replies 4 ·
Replies
4
Views
2K
Replies
2
Views
3K
Replies
7
Views
4K
Replies
8
Views
2K
  • · Replies 100 ·
4
Replies
100
Views
10K
  • · Replies 2 ·
Replies
2
Views
2K
  • · Replies 3 ·
Replies
3
Views
2K
  • · Replies 2 ·
Replies
2
Views
16K